Skip to content
Wenlo
Sign in
← Markets

BioMarin Pharmaceutical Inc.

Gregory R Friberg (EVP, Chief R&D Officer) sells BMRN shares

4BMRNFiled Nov 19, 2026, 1:04 PM ET· Period Nov 18, 2026

About this filing

BioMarin Pharmaceutical Inc. (BMRN) filed Form 4 (insider transaction) with the SEC on Nov 19, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Gregory R Friberg · EVP, Chief R&D Officer
DateTransactionSharesPriceValueHeld afterOwnership
Nov 18, 2026S · open-market saleFootnotes F1−5,147$58.81$302,710.5142,585Direct
Footnotes
  1. F1 The price in column 4 is the weighted average price. The purchase price actually received ranged from $58.77 to $58.855. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

More BMRN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.